0
0
Home » Pharmaceuticals

Hemophilia A (Factor VIII Deficiency) Disease – Global Clinical Trials Review, H1 2020

GlobalData's clinical trial report, “Hemophilia A (Factor VIII Deficiency) Global Clinical Trials Review, H1, 2020" provides an overview of Hemophilia A (Factor VIII Deficiency) Clinical trials scenario. This report provides top line data relating to the clinical trials on Hemophilia A (Factor VIII Deficiency). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma – Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

– Assists in formulating key business strategies with regards to investment

– Helps in identifying prominent locations for conducting clinical trials which saves time and cost

– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

– Supports understanding of trials count and enrollment trends by country in global therapeutics market

– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

– Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Key Players

Novo Holdings AS

Bayer AG

Takeda Pharmaceutical Co Ltd

F. Hoffmann-La Roche Ltd

Pfizer Inc

CSL Ltd

Octapharma AG

Baxter International Inc

Sanofi

Swedish Orphan Biovitrum AB

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Report Guidance 6

GlobalData Clinical Trials Report Coverage 7

Clinical Trials by Region 8

Clinical Trials and Average Enrollment by Country 9

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12

Top Five Countries Contributing to Clinical Trials in Europe 13

Top Countries Contributing to Clinical Trials in North America 14

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15

Top Five Countries Contributing to Clinical Trials in Central and South America 16

Clinical Trials by G7 Countries: Proportion of Hemophilia A (Factor VIII Deficiency) to Hematological Disorders Clinical Trials 17

Clinical Trials by Phase in G7 Countries 18

Clinical Trials in G7 Countries by Trial Status 19

Clinical Trials by E7 Countries: Proportion of Hemophilia A (Factor VIII Deficiency) to Hematological Disorders Clinical Trials 20

Clinical Trials by Phase in E7 Countries 21

Clinical Trials in E7 Countries by Trial Status 22

Clinical Trials by Phase 23

In Progress Trials by Phase 24

Clinical Trials by Trial Status 25

Clinical Trials by End Point Status 26

Subjects Recruited Over a Period of Time 27

Clinical Trials by Sponsor Type 28

Prominent Sponsors 29

Top Companies Participating in Hemophilia A (Factor VIII Deficiency) Therapeutics Clinical Trials 31

Prominent Drugs 33

Latest Clinical Trials News on Hemophilia A (Factor VIII Deficiency) 34

Feb 25, 2020: Sigilon Therapeutics to Present at the 40th Annual Cowen & Co. Health Care Conference 34

Feb 20, 2020: BioMarin's Biologics license application for valoctocogene roxaparvovec accepted for priority review by FDA with review action date of August 21, 2020 34

Feb 06, 2020: Octapharma demonstrates commitment to improving haemophilia A treatment at the 13th annual congress of the European Association for Haemophilia and Allied Disorders (EAHAD) 34

Clinical Trial Profile Snapshots 36

Appendix 341

Abbreviations 341

Definitions 341

Research Methodology 342

Secondary Research 342

About GlobalData 343

Contact Us 343

Source 344

List of Tables

List of Tables

Hemophilia A (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials by Region, 2020* 8

Hemophilia A (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020* 10

Hemophilia A (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020* 11

Hemophilia A (Factor VIII Deficiency) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020* 12

Hemophilia A (Factor VIII Deficiency) Therapeutics Clinical Trials, Europe, Top Five Countries, 2020* 13

Hemophilia A (Factor VIII Deficiency) Therapeutics Clinical Trials, North America, Top Countries, 2020* 14

Hemophilia A (Factor VIII Deficiency) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2020* 15

Hemophilia A (Factor VIII Deficiency) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2020* 16

Proportion of Hemophilia A (Factor VIII Deficiency) to Hematological Disorders Clinical Trials, G7 Countries (%), 2020* 17

Hemophilia A (Factor VIII Deficiency) Therapeutics, G7 Countries, Clinical Trials by Phase, 2020* 18

Hemophilia A (Factor VIII Deficiency) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020* 19

Proportion of Hemophilia A (Factor VIII Deficiency) to Hematological Disorders Clinical Trials, E7 Countries (%), 2020* 20

Hemophilia A (Factor VIII Deficiency) Therapeutics, E7 Countries, Clinical Trials by Phase, 2020* 21

Hemophilia A (Factor VIII Deficiency) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020* 22

Hemophilia A (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials by Phase, 2020* 23

Hemophilia A (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials In Progress by Phase 2020* 24

Hemophilia A (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials by Trial Status, 2020* 25

Hemophilia A (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, by End Point Status, 2020* 26

Hemophilia A (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019 27

Hemophilia A (Factor VIII Deficiency) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020* 28

Hemophilia A (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, Key Sponsors, 2020* 30

Hemophilia A (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020* 32

Hemophilia A (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020* 33

List of Figures

List of Figures

Hemophilia A (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials by Region (%), 2020* 8

Hemophilia A (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020* 9

Hemophilia A (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020* 11

Hemophilia A (Factor VIII Deficiency) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2020* 12

Hemophilia A (Factor VIII Deficiency) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2020* 13

Hemophilia A (Factor VIII Deficiency) Therapeutics Clinical Trials, North America, Top Countries (%), 2020* 14

Hemophilia A (Factor VIII Deficiency) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2020* 15

Hemophilia A (Factor VIII Deficiency) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2020* 16

Proportion of Hemophilia A (Factor VIII Deficiency) to Hematological Disorders Clinical Trials, G7 Countries (%), 2020* 17

Hemophilia A (Factor VIII Deficiency) Therapeutics, G7 Countries, Clinical Trials by Phase, 2020* 18

Hemophilia A (Factor VIII Deficiency) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020* 19

Proportion of Hemophilia A (Factor VIII Deficiency) to Hematological Disorders Clinical Trials, E7 Countries (%), 2020* 20

Hemophilia A (Factor VIII Deficiency) Therapeutics, E7 Countries, Clinical Trials by Phase, 2020* 21

Hemophilia A (Factor VIII Deficiency) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020* 22

Hemophilia A (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials by Phase (%), 2020* 23

Hemophilia A (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials In Progress by Phase, 2020* 24

Hemophilia A (Factor VIII Deficiency) Therapeutics, Global, Clinical Trials by Trial Status, 2020* 25

Hemophilia A (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, by End Point Status, 2020* 26

Hemophilia A (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019 27

Hemophilia A (Factor VIII Deficiency) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2020* 28

Hemophilia A (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, Key Sponsors, 2020* 29

Hemophilia A (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020* 31

Hemophilia A (Factor VIII Deficiency) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020* 33

GlobalData Methodology 342

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2960

Join our mailing list

Saved reports